ACTINIUM PHARMACEUTICALS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $75.00K, a 7400.00% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $261.00K.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $1.00K.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $6.00K.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $75.00K, a 71.37% decline from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $262.00K.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $6.00K, a 83.78% decline from fiscal 2020.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $37.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $75.00K 10-K · filed 2026-03-30 | |
| 2024-03-31 | $75.00K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $262.00K 10-K · filed 2025-03-31 | |
| 2023-06-30 | $261.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $1.00K 10-Q · filed 2024-11-14 | |
| 2021-12-31 | $6.00K 10-K · filed 2023-03-31 | |
| 2021-06-30 | $6.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $37.00K 10-K · filed 2022-03-25 | |
| 2016-12-31 | $18.11K 10-K · filed 2019-03-15 | |
| 2015-12-31 | $15.68K 10-K · filed 2016-03-11 | |
| 2014-12-31 | $275.15K 10-K · filed 2016-03-11 | |
| 2013-12-31 | $13.05K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |